A 'healthy baby': The double imperative of preimplantation genetic diagnosis

Area of Science:

• Reproductive medicine
• Clinical genetics
• Bioethics

Background:

• Preimplantation genetic diagnosis (PGD) is a reproductive technology aimed at preventing serious genetic disorders.
• Unlike in vitro fertilization (IVF), PGD focuses on selecting embryos free from specific genetic conditions to ensure a healthy baby.
• The PGD process involves a dual imperative: embryos must be viable and genetically unaffected.

Purpose of the Study:

• To explore the social processes, meanings, and institutions shaping ethical problems and clinical dilemmas in PGD.
• To investigate the ethical, social, and occupational issues faced by staff involved in PGD.
• To analyze the impact of the 'double imperative' in PGD on clinical practice.

Main Methods:

• Qualitative study exploring the experiences of practitioners, scientists, and staff in PGD.
• Analysis of the social and institutional factors influencing ethical decision-making in PGD.
• Focus on the 'double imperative' of embryo viability and genetic health.

Main Results:

• PGD presents unique ethical and clinical dilemmas stemming from its goal of producing 'healthy babies'.
• Staff navigate complex processes to meet the dual requirements of embryo viability (embryology) and genetic health (genetics).
• The 'double imperative' creates significant ethical, social, and occupational challenges for PGD professionals.

Conclusions:

• The dual screening process in PGD generates distinct ethical and occupational challenges for clinical staff.
• Understanding these challenges is crucial for supporting professionals in the field of PGD.
• The pursuit of 'healthy babies' through PGD necessitates careful consideration of the human and institutional factors involved.